Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy?

Gastroenterology

Volumn 98, Issue 6, 1990, Pages 1420-1426

  Bardram, Linda ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN;

ARTICLE; DUODENUM ULCER; GASTRINOMA; GEL CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

ADOLESCENT; ADULT; AGED; CHROMATOGRAPHY, GEL; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; GASTRINS; HUMAN; MALE; MIDDLE AGE; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL; ZOLLINGER-ELLISON SYNDROME;

EID: 0025241873     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(90)91071-D     Document Type: Article

References (37)

1. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas
2. Molecular cloning of human gastrin cDNA: evidence for evolution of gastrin by gene duplication
3. Molecular cloning of human gastrin precursor cDNA
4. Converting enzymes
5. The constitution and properties of two gastrins extracted from hog antral mucosa
6. Immunoreactive gastrin components in human serum
7. Post-translational processing of the porcine gastrin precursor by phosphorylation of the COOH-terminal fragment
8. Isolation and characterization of the intact gastrin precursor from a gastrinoma
9. Structure-function relationships in the active C-terminal tetrapeptide amide sequence of gastrin
10. Mechanism of C-terminal amide formation by pituitary enzymes
11. Identification and characterization of glycine-extended posttranslational processing intermediates of progastrin in porcine stomach
12. α-Amidation of antral progastrin: relation to other posttranslational modifications
13. Accumulation of nonamidated preprogastrin and preprocholecystokinin products in porcine pituitary corticotrophs. Evidence of posttranslational control of cell differentiation
14. Cell specific processing of pro-cholecystokinin and progastrin
15. Cholecystokinin, gastrin and their precursors in pheochromocytomas
16. Gastrin in human bronchogenic carcinomas: Constant expression but variable processing of progastrin
17. Processing-independent radioimmunoanalysis: a general analytical principle applied to progastrin and its products
18. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas
19. Effects of Omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome
20. The place of surgery in the treatment of gastrointestinal APUD-omas
21. Production and evaluation of monospecific antibodies for a processing-independent sequence of human progastrin
22. Production and evaluation of antibodies for the radioimmunoassay of gastrin
23. Sulfation of gastrin: effect on immunoreactivity
24. Measurement of precursors for α-amidated hormones by radioimmunoassay of glycine-extended peptides after trypsin-carboxypeptidase B cleavage
25. 125I-labelled synthetic human gastrin-I for radioimmunoanalysis
26. 2-terminal tridecapeptide fragment of gastrin-17 in serum from duodenal ulcer patients
27. 2-terminal of gastrin-17 in duodenal ulcer disease: identification of progastrin-17
28. Neither glycine-extended gastrin nor the 1–13 fragment of gastrin-17 influences gastric acid secretion in humans
29. Gelfiltration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients
30. Relative abundance of big and little gastrins in tumours and blood of patients with Zollinger-Ellison syndrome
31. C-terminally glycine-extended gastrins in serum and tumors from patients with the Zollinger-Ellison syndrome (abstr)
32. Aminoterminal gastrin fragment in serum of Zollinger-Ellisons syndrome patients
33. 2-terminal gastrins in gastrinoma syndrome
34. Identification of progastrin in gastrinomas, antrum and duodenum by a novel radioimmunoassay
35. Progastrin processing in hypersecretory G-cells in humans
36. Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues
37. Identification of gastrin molecular variants in gastrinoma syndrome